Clinical outcomes of patients who received a lower dose of non-vitamin K antagonist oral anticoagulants for the medical management of acute pulmonary embolism
JY Shin, JC Choe, JH Ahn, HW Lee, JH Oh… - Acta …, 2022 - Taylor & Francis
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are used to treat acute
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
Clinical outcomes of patients who received a lower dose of non-vitamin K antagonist oral anticoagulants for the medical management of acute pulmonary embolism
JY Shin, JC Choe, JH Ahn, HW Lee… - Acta …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are used to treat acute
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
Clinical outcomes of patients who received a lower dose of non-vitamin K antagonist oral anticoagulants for the medical management of acute pulmonary embolism
JY Shin, JC Choe, JH Ahn, HW Lee, JH Oh… - Acta …, 2022 - ingentaconnect.com
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are used to treat acute
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
Clinical outcomes of patients who received a lower dose of non-vitamin K antagonist oral anticoagulants for the medical management of acute pulmonary embolism.
JY Shin, JC Choe, JH Ahn, HW Lee, JH Oh… - Acta …, 2021 - europepmc.org
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are used to treat acute
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …
pulmonary embolism (PE). However, lower NOAC doses are often prescribed because of …